Titan's partnership with Ximedica may be of more importance than any of us imagined. My gut says theyve done the right thing when it comes to regulatory consultation. FDA is THE rate-limiting factor. Ive said that since the time I joined this message board. Im really curious to see how this shakes up the investment community in this space. Titan is officially "next in line."
Maybe but i think this news just makes the company that much more valuable after they receive FDA approval. I think the price goes way up after approval vs before, even more so now than before. i hope they get approval before any buy out is made.
News 
Market Data 
Discover 
